References: Cell Metabolism (2024)
Saxenda (Liraglutide) Injection, for Subcutaneous Use: Prescribing Information
FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available
NAD vs NAC: Key Differences in Structure and Function Image Source: ResearchGate The structural and functional differences between NAD and NAC show why these compounds play distinct yet complementary roles in cellular health
GLP-1 (glucagon-like peptide-1) is a hormone produced by specialized cells in your intestine called L-cells
Exfoliation may help support skin renewal and complement a corrective skincare routine when used appropriately